What is Oruka Therapeutics, Inc.'s stock-based comp?

Oruka Therapeutics, Inc. (ORKA) reported stock-based comp of $6.97M in Q1 2026.

How has Oruka Therapeutics, Inc.'s stock-based comp changed year-over-year?

Oruka Therapeutics, Inc.'s stock-based comp increased by 42.7% year-over-year, from $4.88M to $6.97M.

Oruka Therapeutics, Inc. ORKA Stock-Based Comp

Stock-Based Comp at other companies

Ford Motor CompanyF

$110M-9.1%

Trane TechnologiesTT

$26.8M+20.7%

EVR

EvergyEVRG

$5.6M+24.4%

ROP

Roper Technologies, Inc.ROP

$52.6M+35.6%

WAT

Waters CorporationWAT

$20M+53.8%

The Carlyle GroupCG

$119.8M+15.7%

Other financials

Income statement

See full

Revenue-—

Operating income-$36.4M-45.2%

Net income-$31.8M-51.5%

EPS (diluted)-$0.46+93.4%

Balance sheet

See full

Cash & equivalents$49.5M-40.7%

Total debt$1.8M+90.8%

Total equity$486.7M+33.4%

Total assets$504.5M+33.8%

Cash flow

See full

Operating cash flow-$23.6M-13.0%

CapEx$73.0K+462%

Free cash flow-$23.7M-13.3%

Valuation

See full

Market cap$5.03B+533%

Returns & leverage

See full

Return on equity-27.3%-11.1pp

Debt / equity0×0.0×

Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s stock-based comp?: Oruka Therapeutics, Inc. (ORKA) reported stock-based comp of $6.97M in Q1 2026.
How has Oruka Therapeutics, Inc.'s stock-based comp changed year-over-year?: Oruka Therapeutics, Inc.'s stock-based comp increased by 42.7% year-over-year, from $4.88M to $6.97M.